{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T19:52:57Z","timestamp":1764791577897,"version":"3.46.0"},"reference-count":36,"publisher":"Archives of Pathology and Laboratory Medicine","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,1,1]]},"abstract":"<jats:sec>\n                    <jats:title>Context.\u2014<\/jats:title>\n                    <jats:p>Unsatisfactory Papanicolaou (Pap) tests pose a unique set of challenges to the laboratory with regard to their processing, review, reporting, and performance of human papillomavirus (HPV) testing. There are no standardized guidelines for the review process and handling of unsatisfactory Pap tests.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective.\u2014<\/jats:title>\n                    <jats:p>To assess the current practice patterns regarding various aspects of the unsatisfactory Pap test, from processing to reporting, across laboratories worldwide.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design.\u2014<\/jats:title>\n                    <jats:p>A supplemental questionnaire was mailed to laboratories participating in the 2020 College of American Pathologists (CAP) Gynecologic Cytopathology (PAP Education) Program, requesting data regarding the unsatisfactory Pap test.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results.\u2014<\/jats:title>\n                    <jats:p>Of 1520 participating laboratories, 619 (40.7%) responded, and the responses of 577 laboratories were included for further analysis. Only 64.6% (373 of 577) laboratories used the unsatisfactory Pap test criteria as specified by the 2014 Bethesda System. About three-quarters of the respondents (433 of 576; 75.2%) routinely rescreened unsatisfactory Pap tests. Routine repreparation of such Pap tests was performed by 54.9% (316 of 576) of laboratories, and 52.0% (293 of 563) used glacial acetic acid for repreparing excessively bloody specimens. HPV test results were reported for unsatisfactory Pap tests, always or sometimes, by 62.4% (353 of 566) of respondents.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions.\u2014<\/jats:title>\n                    <jats:p>This CAP survey reveals important information regarding the practice patterns pertaining to several aspects of the unsatisfactory Pap test. It also provides valuable insight into the quality assurance measures that can be implemented for such tests. Future studies can further aid in the standardization of all components of the handling of unsatisfactory Pap tests for overall quality improvement.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.5858\/arpa.2022-0330-cp","type":"journal-article","created":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T12:03:03Z","timestamp":1681905783000},"page":"48-54","source":"Crossref","is-referenced-by-count":1,"title":["Navigating Practice Issues Related to the Unsatisfactory Cervicovaginal Papanicolaou Test: Survey Results of Laboratories Participating in the 2020 College of American Pathologists PAP Education Program"],"prefix":"10.5858","volume":"148","author":[{"given":"Abha","family":"Goyal","sequence":"first","affiliation":[{"name":"From the Department of Pathology and Laboratory Medicine, Weill Cornell Medicine\/New York-Presbyterian Hospital, New York, New York (Goyal)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine N.","family":"Booth","sequence":"additional","affiliation":[{"name":"the Department of Pathology, Cleveland Clinic, Cleveland, Ohio (Booth)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rhona J.","family":"Souers","sequence":"additional","affiliation":[{"name":"the Departments of Biostatistics (Souers) and Proficiency Testing (Goodrich), College of American Pathologists, Northfield, Illinois"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sana O.","family":"Tabbara","sequence":"additional","affiliation":[{"name":"the Department of Pathology, H. Lee Moffitt Cancer Center, Tampa, Florida (Tabbara)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janie","family":"Roberson","sequence":"additional","affiliation":[{"name":"the Department of Pathology, University of Alabama Birmingham Hospital, Birmingham (Roberson)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael R.","family":"Henry","sequence":"additional","affiliation":[{"name":"the Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota (Henry)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaitlin E.","family":"Sundling","sequence":"additional","affiliation":[{"name":"the Department of Pathology and Laboratory Medicine, Wisconsin State Laboratory of Hygiene and University of Wisconsin, Madison (Sundling)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly","family":"Goodrich","sequence":"additional","affiliation":[{"name":"the Departments of Biostatistics (Souers) and Proficiency Testing (Goodrich), College of American Pathologists, Northfield, Illinois"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lananh","family":"Nguyen","sequence":"additional","affiliation":[{"name":"the Department of Laboratory Medicine & Pathobiology, University of Toronto, Toronto, Ontario, Canada (Nguyen)"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3906","published-online":{"date-parts":[[2023,4,19]]},"reference":[{"key":"2024010215140515800_i1543-2165-148-1-48-b01","doi-asserted-by":"crossref","unstructured":"The 1988 Bethesda System for reporting cervical\/vaginal cytologic diagnoses.\nDeveloped and approved at the National Cancer Institute Workshop,\nBethesda, Maryland, U.S.A.,\nDecember 12-13, 1988.\nActa Cytol.\n1989;\n33(5):\n567\u2013\n574.","DOI":"10.1002\/dc.2840050318"},{"key":"2024010215140515800_i1543-2165-148-1-48-b02","doi-asserted-by":"crossref","unstructured":"Solomon\n              D,\n            \n            \n              Davey\n              D,\n            \n            \n              Kurman\n              R,\n            \n            et al.\n          \n          The 2001 Bethesda System: terminology for reporting results of cervical cytology.\nJAMA.\n2002;\n287(16):\n2114\u2013\n2119.","DOI":"10.1001\/jama.287.16.2114"},{"key":"2024010215140515800_i1543-2165-148-1-48-b03","doi-asserted-by":"crossref","unstructured":"Davey\n              DD,\n            \n            \n              Neal\n              MH,\n            \n            \n              Wilbur\n              DC,\n            \n            \n              Colgan\n              TJ,\n            \n            \n              Styer\n              PE,\n            \n            \n              Mody\n              DR.\n            \n          \n          Bethesda 2001 implementation and reporting rates: 2003 practices of participants in the College of American Pathologists Interlaboratory Comparison Program in Cervicovaginal Cytology.\nArch Pathol Lab Med.\n2004;\n128(11):\n1224\u2013\n1229.","DOI":"10.5858\/2004-128-1224-BIARRP"},{"key":"2024010215140515800_i1543-2165-148-1-48-b04","doi-asserted-by":"crossref","unstructured":"Moriarty\n              AT,\n            \n            \n              Clayton\n              AC,\n            \n            \n              Zaleski\n              S,\n            \n            et al.\n          \n          Unsatisfactory reporting rates: 2006 practices of participants in the College of American Pathologists interlaboratory comparison program in gynecologic cytology.\nArch Pathol Lab Med.\n2009;\n133(12):\n1912\u2013\n1916.","DOI":"10.5858\/133.12.1912"},{"key":"2024010215140515800_i1543-2165-148-1-48-b05","doi-asserted-by":"crossref","unstructured":"Eversole\n              GM,\n            \n            \n              Moriarty\n              AT,\n            \n            \n              Schwartz\n              MR,\n            \n            et al.\n          \n          Practices of participants in the college of american pathologists interlaboratory comparison program in cervicovaginal cytology, 2006.\nArch Pathol Lab Med.\n2010;\n134(3):\n331\u2013\n335.","DOI":"10.5858\/134.3.331"},{"key":"2024010215140515800_i1543-2165-148-1-48-b06","doi-asserted-by":"crossref","unstructured":"Biscotti\n              CV,\n            \n            \n              Dawson\n              AE,\n            \n            \n              Dziura\n              B,\n            \n            et al.\n          \n          Assisted primary screening using the automated ThinPrep Imaging System.\nAm J Clin Pathol.\n2005;\n123(2):\n281\u2013\n287.","DOI":"10.1309\/AGB1MJ9H5N43MEGX"},{"key":"2024010215140515800_i1543-2165-148-1-48-b07","doi-asserted-by":"crossref","unstructured":"Wilbur\n              DC,\n            \n            \n              Black-Schaffer\n              WS,\n            \n            \n              Luff\n              RD,\n            \n            et al.\n          \n          The Becton Dickinson FocalPoint GS Imaging System: clinical trials demonstrate significantly improved sensitivity for the detection of important cervical lesions.\nAm J Clin Pathol.\n2009;\n132(5):\n767\u2013\n775.","DOI":"10.1309\/AJCP8VE7AWBZCVQT"},{"key":"2024010215140515800_i1543-2165-148-1-48-b08","doi-asserted-by":"crossref","unstructured":"Wright\n              TC,\n            \n            \n              Schiffman\n              M,\n            \n            \n              Solomon\n              D,\n            \n            et al.\n          \n          Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening.\nObstet Gynecol.\n2004;\n103(2):\n304\u2013\n309.","DOI":"10.1097\/01.AOG.0000109426.82624.f8"},{"key":"2024010215140515800_i1543-2165-148-1-48-b09","doi-asserted-by":"crossref","unstructured":"Wright\n              TC,\n            \n            \n              Massad\n              LS,\n            \n            \n              Dunton\n              CJ,\n            \n            et al.\n          \n          2006 consensus guidelines for the management of women with abnormal cervical screening tests.\nJ Low Genit Tract Dis.\n2007;\n11(4):\n201\u2013\n222.","DOI":"10.1097\/LGT.0b013e3181585870"},{"key":"2024010215140515800_i1543-2165-148-1-48-b10","doi-asserted-by":"crossref","unstructured":"Nayar\n              R,\n            \n            \n              Wilbur\n              DC.\n            \n          \n          The Pap Test and Bethesda 2014: \u201cThe reports of my demise have been greatly exaggerated.\u201d (after a quotation from Mark Twain).\nActa Cytol.\n2015;\n59(2):\n121\u2013\n132.","DOI":"10.1159\/000381842"},{"key":"2024010215140515800_i1543-2165-148-1-48-b11","doi-asserted-by":"crossref","unstructured":"Bentz\n              JS,\n            \n            \n              Rowe\n              LR,\n            \n            \n              Gopez\n              EV,\n            \n            \n              Marshall\n              CJ.\n            \n          \n          The unsatisfactory ThinPrep Pap Test: missed opportunity for disease detection?\n          \n            Am J Clin Pathol\n          .\n2002;\n117(3):\n457\u2013\n463.","DOI":"10.1309\/XMQP-9AJD-104W-07C8"},{"key":"2024010215140515800_i1543-2165-148-1-48-b12","doi-asserted-by":"crossref","unstructured":"Rosa\n              M,\n            \n            \n              Pragasam\n              P,\n            \n            \n              Saremian\n              J,\n            \n            \n              Aoalin\n              A,\n            \n            \n              Graf\n              W,\n            \n            \n              Mohammadi\n              A.\n            \n          \n          The unsatisfactory ThinPrep\u00ae Pap Test\u2122: analysis of technical aspects, most common causes, and recommendations for improvement.\nDiagn Cytopathol.\n2013;\n41(7):\n588\u2013\n594.","DOI":"10.1002\/dc.22904"},{"key":"2024010215140515800_i1543-2165-148-1-48-b13","doi-asserted-by":"crossref","unstructured":"Haack\n              LA,\n            \n            \n              O'Brien\n              D,\n            \n            \n              Selvaggi\n              SM.\n            \n          \n          Protocol for the processing of bloody cervical specimens: glacial acetic acid and the ThinPrep Pap Test.\nDiagn Cytopathol.\n2006;\n34(3):\n210\u2013\n213.","DOI":"10.1002\/dc.20437"},{"key":"2024010215140515800_i1543-2165-148-1-48-b14","doi-asserted-by":"crossref","unstructured":"Pang\n              Y,\n            \n            \n              Smola\n              B,\n            \n            \n              Pu\n              RT,\n            \n            \n              Michael\n              CW.\n            \n          \n          Restoring satisfactory status in ThinPrep Pap test specimens with too few squamous cells and containing microscopic red blood cells.\nDiagn Cytopathol.\n2008;\n36(10):\n696\u2013\n700.","DOI":"10.1002\/dc.20890"},{"key":"2024010215140515800_i1543-2165-148-1-48-b15","doi-asserted-by":"crossref","unstructured":"Owens\n              CL,\n            \n            \n              Buist\n              DS,\n            \n            \n              Peterson\n              D,\n            \n            et al.\n          \n          Follow-up and clinical significance of unsatisfactory liquid-based Papanicolaou tests.\nCancer Cytopathol.\n2015;\n123(1):\n59\u2013\n65.","DOI":"10.1002\/cncy.21490"},{"key":"2024010215140515800_i1543-2165-148-1-48-b16","doi-asserted-by":"crossref","unstructured":"Zhao\n              C,\n            \n            \n              Austin\n              RM.\n            \n          \n          High-risk human papillomavirus DNA test results are useful for disease risk stratification in women with unsatisfactory liquid-based cytology pap test results.\nJ Low Genit Tract Dis.\n2009;\n13(2):\n79\u2013\n84.","DOI":"10.1097\/LGT.0b013e31818474fd"},{"key":"2024010215140515800_i1543-2165-148-1-48-b17","doi-asserted-by":"crossref","unstructured":"Davey\n              DD,\n            \n            \n              Souers\n              RJ,\n            \n            \n              Goodrich\n              K,\n            \n            \n              Mody\n              DR,\n            \n            \n              Tabbara\n              SO,\n            \n            \n              Booth\n              CN.\n            \n          \n          Bethesda 2014 implementation and human papillomavirus primary screening: practices of laboratories participating in the College of American Pathologists PAP Education Program.\nArch Pathol Lab Med.\n2019;\n143(10):\n1196\u2013\n1202.","DOI":"10.5858\/arpa.2018-0603-CP"},{"key":"2024010215140515800_i1543-2165-148-1-48-b18","doi-asserted-by":"crossref","unstructured":"Owens\n              CL,\n            \n            \n              Peterson\n              D,\n            \n            \n              Kamineni\n              A,\n            \n            et al.\n          \n          Effects of transitioning from conventional methods to liquid-based methods on unsatisfactory Papanicolaou tests: results from a multicenter US study.\nCancer Cytopathol.\n2013;\n121(10):\n568\u2013\n575.","DOI":"10.1002\/cncy.21309"},{"key":"2024010215140515800_i1543-2165-148-1-48-b19","doi-asserted-by":"crossref","unstructured":"Fontaine\n              D,\n            \n            \n              Narine\n              N,\n            \n            \n              Naugler\n              C.\n            \n          \n          Unsatisfactory rates vary between cervical cytology samples prepared using ThinPrep and SurePath platforms: a review and meta-analysis.\nBMJ Open.\n2012;\n2(2):\ne000847.","DOI":"10.1136\/bmjopen-2012-000847"},{"key":"2024010215140515800_i1543-2165-148-1-48-b20","unstructured":"College of American Pathologists Cytopathology checklist.\nhttps:\/\/www.cap.org\/laboratory-improvement\/accreditation\/accreditation-checklists. AccessedFebruary25,2022."},{"key":"2024010215140515800_i1543-2165-148-1-48-b21","doi-asserted-by":"crossref","unstructured":"Belinson\n              JL,\n            \n            \n              Pan\n              QJ,\n            \n            \n              Biscotti\n              C,\n            \n            et al.\n          \n          Primary screening with liquid-based cytology in an unscreened population in rural China, with an emphasis on reprocessing unsatisfactory samples.\nActa Cytol.\n2002;\n46(3):\n470\u2013\n474.","DOI":"10.1159\/000326863"},{"key":"2024010215140515800_i1543-2165-148-1-48-b22","doi-asserted-by":"crossref","unstructured":"Cohen\n              D,\n            \n            \n              Shorie\n              J,\n            \n            \n              Biscotti\n              C.\n            \n          \n          Glacial acetic acid treatment and atypical endocervical glandular cells: an analysis of 92 cases.\nAm J Clin Pathol.\n2010;\n133(5):\n799\u2013\n801.","DOI":"10.1309\/AJCP8N9ZJQDHFYTC"},{"key":"2024010215140515800_i1543-2165-148-1-48-b23","doi-asserted-by":"crossref","unstructured":"Agoff\n              SN,\n            \n            \n              Dean\n              T,\n            \n            \n              Nixon\n              BK,\n            \n            \n              Ingalls-Severn\n              K,\n            \n            \n              Rinker\n              L,\n            \n            \n              Grieco\n              VS.\n            \n          \n          The efficacy of reprocessing unsatisfactory cervicovaginal ThinPrep specimens with and without glacial acetic acid: effect on Hybrid Capture II human papillomavirus testing and clinical follow-up.\nAm J Clin Pathol.\n2002;\n118(5):\n727\u2013\n732.","DOI":"10.1309\/GE86-156K-EGM2-DGXB"},{"key":"2024010215140515800_i1543-2165-148-1-48-b24","doi-asserted-by":"crossref","unstructured":"Munson\n              E,\n            \n            \n              Schroeder\n              ER,\n            \n            \n              Ross\n              KC,\n            \n            et al.\n          \n          Effect of preanalytical processing of ThinPrep specimens on detection of high-risk human papillomavirus by the Aptima HPV assay.\nJ Clin Microbiol.\n2014;\n52(5):\n1448\u2013\n1452.","DOI":"10.1128\/JCM.03624-13"},{"key":"2024010215140515800_i1543-2165-148-1-48-b25","doi-asserted-by":"crossref","unstructured":"Rowe\n              LR,\n            \n            \n              Bentz\n              JS.\n            \n          \n          A simple method to determine the need for glacial acetic acid treatment of bloody ThinPrep Pap tests before slide processing.\nDiagn Cytopathol.\n2004;\n31(5):\n321\u2013\n325.","DOI":"10.1002\/dc.20152"},{"key":"2024010215140515800_i1543-2165-148-1-48-b26","unstructured":"ThinPrep imaging system operator's manual.\nhttps:\/\/www.hologic.com\/sites\/default\/files\/2017-12\/MAN-04199-001_002_02.pdf. AccessedJanuary15,2022."},{"key":"2024010215140515800_i1543-2165-148-1-48-b27","doi-asserted-by":"crossref","unstructured":"Massad\n              LS,\n            \n            \n              Einstein\n              MH,\n            \n            \n              Huh\n              WK,\n            \n            et al.\n          \n          2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors.\nJ Low Genit Tract Dis.\n2013;\n17(5 suppl 1):\nS1\u2013\nS27.","DOI":"10.1097\/LGT.0b013e318287d329"},{"key":"2024010215140515800_i1543-2165-148-1-48-b28","doi-asserted-by":"crossref","unstructured":"Perkins\n              RB,\n            \n            \n              Guido\n              RS,\n            \n            \n              Castle\n              PE,\n            \n            et al.\n          \n          2019 ASCCP risk-based management consensus guidelines for abnormal cervical cancer screening tests and cancer precursors.\nJ Low Genit Tract Dis.\n2020;\n24(2):\n102\u2013\n131.","DOI":"10.1097\/LGT.0000000000000525"},{"key":"2024010215140515800_i1543-2165-148-1-48-b29","doi-asserted-by":"crossref","unstructured":"Nayar\n              R,\n            \n            \n              Goulart\n              RA,\n            \n            \n              Davey\n              DD.\n            \n          \n          Primary HPV cervical cancer screening in the United States: are we ready?\n          \n            J Am Soc Cytopathol\n          .\n2018;\n7(1):\n50\u2013\n55.","DOI":"10.1016\/j.jasc.2017.12.001"},{"key":"2024010215140515800_i1543-2165-148-1-48-b30","unstructured":"Clinical Laboratory Improvement Amendments of 1988: final rule.\nFed Regist.\n1992;\n57:\n7001\u2013\n7186.\n(Current CLIA regulations: https:\/\/www.cdc.gov\/clia\/law-regulations.html. Accessed March 20, 2022.)"},{"key":"2024010215140515800_i1543-2165-148-1-48-b31","doi-asserted-by":"crossref","unstructured":"Nyg\u00e5rd\n              JF,\n            \n            \n              Sauer\n              T,\n            \n            \n              Nyg\u00e5rd\n              M,\n            \n            \n              Skare\n              GB,\n            \n            \n              Thoresen\n              S\u00d8. CIN\n            \n          \n          2\/3 and cervical cancer in an organised screening programme after an unsatisfactory or a normal Pap smear: a seven-year prospective study of the Norwegian population-based screening programme.\nJ Med Screen.\n2004;\n11(2):\n70\u2013\n76.","DOI":"10.1258\/096914104774061047"},{"key":"2024010215140515800_i1543-2165-148-1-48-b32","doi-asserted-by":"crossref","unstructured":"Ransdell\n              JS,\n            \n            \n              Davey\n              DD,\n            \n            \n              Zaleski\n              S.\n            \n          \n          Clinicopathologic correlation of the unsatisfactory Papanicolaou smear.\nCancer.\n1997;\n81(3):\n139\u2013\n143.","DOI":"10.1002\/(SICI)1097-0142(19970625)81:3<139::AID-CNCR2>3.0.CO;2-M"},{"key":"2024010215140515800_i1543-2165-148-1-48-b33","doi-asserted-by":"crossref","unstructured":"Quiroga-Garza\n              G,\n            \n            \n              Satrum\n              LS,\n            \n            \n              Trujillo\n              CJ,\n            \n            \n              Mody\n              DR,\n            \n            \n              Ge\n              Y.\n            \n          \n          Common causes for unsatisfactory Pap tests in a high-risk population: insights into a yet unresolved problem in gynecologic cytology.\nJ Am Soc Cytopathol.\n2014;\n3(5):\n256\u2013\n260.","DOI":"10.1016\/j.jasc.2014.05.003"},{"key":"2024010215140515800_i1543-2165-148-1-48-b34","doi-asserted-by":"crossref","unstructured":"Alsharif\n              M,\n            \n            \n              McKeon\n              DM,\n            \n            \n              Gulbahce\n              HE,\n            \n            \n              Savik\n              K,\n            \n            \n              Pambuccian\n              SE.\n            \n          \n          Unsatisfactory SurePath liquid-based Papanicolaou tests: causes and significance.\nCancer.\n2009;\n117(1):\n15\u2013\n26.","DOI":"10.1002\/cncy.20009"},{"key":"2024010215140515800_i1543-2165-148-1-48-b35","doi-asserted-by":"crossref","unstructured":"Siebers\n              AG,\n            \n            \n              Klinkhamer\n              PJ,\n            \n            \n              Vedder\n              JE,\n            \n            \n              Arbyn\n              M,\n            \n            \n              Bulten\n              J.\n            \n          \n          Causes and relevance of unsatisfactory and satisfactory but limited smears of liquid-based compared with conventional cervical cytology.\nArch Pathol Lab Med.\n2012;\n136(1):\n76\u2013\n83.","DOI":"10.5858\/arpa.2011-0113-OA"},{"key":"2024010215140515800_i1543-2165-148-1-48-b36","doi-asserted-by":"crossref","unstructured":"Adams\n              AL,\n            \n            \n              Gidley\n              J,\n            \n            \n              Roberson\n              J,\n            \n            \n              Wang\n              W,\n            \n            \n              Eltoum\n              I,\n            \n            \n              Chhieng\n              DC.\n            \n          \n          Clinical significance of unsatisfactory conventional pap smears owing to inadequate squamous cellularity defined by the Bethesda 2001 criterion.\nAm J Clin Pathol.\n2005;\n123(5):\n738\u2013\n743.","DOI":"10.1309\/GA19KPY3YLMKVWYU"}],"container-title":["Archives of Pathology &amp; Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/meridian.allenpress.com\/aplm\/article-pdf\/148\/1\/48\/3308620\/i1543-2165-148-1-48.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/meridian.allenpress.com\/aplm\/article-pdf\/148\/1\/48\/3308620\/i1543-2165-148-1-48.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T19:40:03Z","timestamp":1764790803000},"score":1,"resource":{"primary":{"URL":"https:\/\/aplm.kglmeridian.com\/view\/journals\/arpa\/148\/1\/article-p48.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,19]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,4,19]]},"published-print":{"date-parts":[[2024,1,1]]}},"URL":"https:\/\/doi.org\/10.5858\/arpa.2022-0330-cp","relation":{},"ISSN":["1543-2165","0003-9985"],"issn-type":[{"type":"electronic","value":"1543-2165"},{"type":"print","value":"0003-9985"}],"subject":[],"published":{"date-parts":[[2023,4,19]]}}}